Developer docs
API playgroundTry for free, no card

Search company profiles

Kairos Ventures

Full company profile

uuid0000lfh

Namestring
Kairos Ventures
Legal namestring
Kairos Venture Investments, LLC
Company typeenum
Private
Founded yearint
2015
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBeverly Hills, United States
HQ citystring
Beverly Hills
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital investing, early-stage investments, university spinout funding, life sciences investing, physical sciences investing
NAICS code2 codes
  • All Other Financial Investment Activities52399
  • Management of Companies and Enterprises55111
Product category
Venture Capital
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Venture Capital Returns
TypeLicensing Royalties
Description

Kairos generates returns through carried interest on successful portfolio company exits including acquisitions, IPOs, and secondary transactions. The firm invests in companies across life sciences and physical sciences sectors with the goal of significant impact and shareholder returns.

kairosventures.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details1 tier
1Early-stage investments from university spinouts
ModelOtherBilling cadenceMulti-year contract
Notes

Investments range from $150,000 for early formative stage companies to $20 million for more developed ventures

kairosventures.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Kairos Ventures is a venture capital firm that makes early-stage investments ranging from $150,000 to $20 million in formative companies spun out of top universities and scientists' research. The firm invests across life sciences and physical sciences sectors, providing hands-on operational expertise in legal, finance, marketing, operations, business development, and HR to help scientists commercialize their technologies into sustainable businesses while allowing founding teams to retain majority ownership.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Kairos Ventures is a venture capital and investment firm that invests in ideas, patents, and businesses from the world's top universities and scientists. The firm invests early-stage capital (ranging from $150,000 to $20 million) in formative companies and works closely with scientists to commercialize their technologies. The portfolio includes over 30 active companies spanning life sciences (therapeutics, medical devices, diagnostics), physical sciences (advanced materials, semiconductors, aerospace), and sustainability sectors. Kairos provides hands-on support including expertise in legal, finance, marketing, operations, business development, and HR. The firm maintains corporate headquarters in Beverly Hills with regional offices in Pasadena, New York, Washington D.C., and Austin.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Strategic deep tech investor affiliated with the US intelligence community, funding university-originated technologies in semiconductors, photonics, and aerospace — directly comparable to MixComm-style investments in Kairos's portfolio.

TypeDirect peer
Description

Deep tech and science-driven venture firm investing in compute, materials, life sciences, and aerospace — directly overlapping with Kairos's physical sciences portfolio and university sourcing approach.

TypeDirect peer
Description

Pioneer in university-originated deep tech and life sciences investing, with similar focus on spinouts from top-tier research institutions and Nobel-laureate-adjacent founders. Closest model peer for early-stage science commercialization.

TypeDirect peer
Description

Dedicated university technology transfer investor, partnering with research institutions to fund spinouts. Highly comparable university-tech-transfer sourcing model, though typically takes smaller equity stakes.

TypeBroad incumbent
Description

Mega-VC with dedicated bio/health and deep tech franchises. Operates overlapping themes (AI, biotech, semiconductors) but with vastly greater AUM, brand, and platform resources.

TypeDirect peer
Description

Leads/participates in early-stage deep tech and biotech rounds (e.g., Vivodyne Series A) with similar formative-stage and impact-oriented thesis. Comparable check sizes and stage focus to Kairos.

TypeBroad incumbent
Description

Established deep tech and frontier technology investor. Overlapping sector mandate (aerospace, biotech, AI) but operates at much larger fund scale with broader stage range than Kairos.

TypeDirect peer
Description

Early-stage VC specializing in university- and scientist-sourced deep tech across life sciences, semiconductors, AI, and aerospace. Most direct comparable to Kairos's university-tech-transfer model and sector mix.

TypeDirect peer
Description

Science-driven venture firm investing across biotech, life sciences, and frontier technology. Comparable thesis around university-sourced IP and operator-led support model.

TypeEmerging player
Description

Early-stage fund focused on novel materials, advanced manufacturing, and physical sciences spinouts. Highly comparable to Kairos's physical sciences portfolio focus (e.g., PolyCera, nFugue, Mattiq).

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers11 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles16 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment72 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Kairos Ventures

Venture Capitalkairosventures.com

Kairos Ventures firmographics

Firmographics
Name
Kairos Ventures
Legal name
Kairos Venture Investments, LLC
Website
https://kairosventures.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Where Kairos Ventures is headquartered

Location

Headquarters

HQ city
Beverly Hills
HQ country
United States
HQ region
North America

Offices5 records

Markets served

Kairos Ventures business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Venture Capital Returns: Kairos generates returns through carried interest on successful portfolio company exits including acquisitions, IPOs, and secondary transactions. The firm invests in companies across life sciences and physical sciences sectors with the goal of significant impact and shareholder returns.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractEarly-stage investments from university spinouts

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Kairos Ventures product offering

Product offering

Core offering

Kairos Ventures is a venture capital firm that makes early-stage investments ranging from $150,000 to $20 million in formative companies spun out of top universities and scientists' research. The firm invests across life sciences and physical sciences sectors, providing hands-on operational expertise in legal, finance, marketing, operations, business development, and HR to help scientists commercialize their technologies into sustainable businesses while allowing founding teams to retain majority ownership.

Product overview

Kairos Ventures is a venture capital and investment firm that invests in ideas, patents, and businesses from the world's top universities and scientists. The firm invests early-stage capital (ranging from $150,000 to $20 million) in formative companies and works closely with scientists to commercialize their technologies. The portfolio includes over 30 active companies spanning life sciences (therapeutics, medical devices, diagnostics), physical sciences (advanced materials, semiconductors, aerospace), and sustainability sectors. Kairos provides hands-on support including expertise in legal, finance, marketing, operations, business development, and HR. The firm maintains corporate headquarters in Beverly Hills with regional offices in Pasadena, New York, Washington D.C., and Austin.

Differentiator

Problem solved

Functional benefit

Companies that use Kairos Ventures

Customer profile

Named customers11 records

Segments3 records

Ideal customer profiles2 records

Kairos Ventures technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Kairos Ventures partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Kairos Ventures competitors and assessment

Company assessment

Emerging players

  • In-Q-Tel: Strategic deep tech investor affiliated with the US intelligence community, funding university-originated technologies in semiconductors, photonics, and aerospace — directly comparable to MixComm-style investments in Kairos's portfolio.
  • Material Impact: Early-stage fund focused on novel materials, advanced manufacturing, and physical sciences spinouts. Highly comparable to Kairos's physical sciences portfolio focus (e.g., PolyCera, nFugue, Mattiq).

Direct peers

  • DCVC (Data Collective): Deep tech and science-driven venture firm investing in compute, materials, life sciences, and aerospace — directly overlapping with Kairos's physical sciences portfolio and university sourcing approach.
  • ARCH Venture Partners: Pioneer in university-originated deep tech and life sciences investing, with similar focus on spinouts from top-tier research institutions and Nobel-laureate-adjacent founders. Closest model peer for early-stage science commercialization.
  • Osage University Partners: Dedicated university technology transfer investor, partnering with research institutions to fund spinouts. Highly comparable university-tech-transfer sourcing model, though typically takes smaller equity stakes.
  • Khosla Ventures: Leads/participates in early-stage deep tech and biotech rounds (e.g., Vivodyne Series A) with similar formative-stage and impact-oriented thesis. Comparable check sizes and stage focus to Kairos.
  • Lux Capital: Early-stage VC specializing in university- and scientist-sourced deep tech across life sciences, semiconductors, AI, and aerospace. Most direct comparable to Kairos's university-tech-transfer model and sector mix.
  • Section 32: Science-driven venture firm investing across biotech, life sciences, and frontier technology. Comparable thesis around university-sourced IP and operator-led support model.

Broad incumbents

  • Andreessen Horowitz (a16z): Mega-VC with dedicated bio/health and deep tech franchises. Operates overlapping themes (AI, biotech, semiconductors) but with vastly greater AUM, brand, and platform resources.
  • Founders Fund: Established deep tech and frontier technology investor. Overlapping sector mandate (aerospace, biotech, AI) but operates at much larger fund scale with broader stage range than Kairos.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Kairos Ventures social profiles

Digital presence

Kairos Ventures financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Kairos Ventures leadership team

Management profile

Number of profiles

Profiles16 records

Kairos Ventures funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Kairos Ventures M&A and investment

M&A and investment

M&A

Investments72 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kairos Ventures

What does Kairos Ventures do?

Kairos Ventures is a venture capital firm that makes early-stage investments ranging from $150,000 to $20 million in formative companies spun out of top universities and scientists' research. The firm invests across life sciences and physical sciences sectors, providing hands-on operational expertise in legal, finance, marketing, operations, business development, and HR to help scientists commercialize their technologies into sustainable businesses while allowing founding teams to retain majority ownership.

Is Kairos Ventures a public or private company?

Kairos Ventures is a private company. It is classified as venture growth investor backed and is currently operating.

When was Kairos Ventures founded?

Kairos Ventures was founded in 2015. It employs 11 to 50 people.

Where is Kairos Ventures based?

Kairos Ventures is headquartered in Beverly Hills, United States, in the North America region.

How does Kairos Ventures make money?

One revenue line is on record: venture Capital Returns.

Who are Kairos Ventures's main competitors?

Emerging players on record are In-Q-Tel and Material Impact. Direct peers are DCVC (Data Collective), ARCH Venture Partners, Osage University Partners, Khosla Ventures, Lux Capital and Section 32. Broad incumbents are Andreessen Horowitz (a16z) and Founders Fund.

Does Kairos Ventures have an API?

No public API is recorded for Kairos Ventures.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AffarsvarldenStorägaren fortsätter att sälja i SiversKairos Ventures, a major shareholder related to Sivers Semiconductors board member Todd Thomson, sold an additional 3.5 million shares in Sivers Semiconductors at 34.70 SEK per share, worth approximately 121.5 million SEK. The sales, reported through Finansinspektionen's insider registry after market close, mark the continuation of daily disposals following the expiration of a lock-up agreement on July 16, bringing total sales to over 300 million SEK in the past week. Sivers Semiconductors' share price declined nearly 8% on Wednesday amid ongoing selling by board members and major shareholders.Inc42Exclusive: Pernia’s Pop Up Shop Raises ₹162 Cr Debt Following SEBI IPO NodPurple Style Labs (PSL), parent company of luxury fashion brand Pernia's Pop Up Shop, raised approximately ₹162.5 Cr (~$17 Mn) across 14 tranches between January and June 2025, issuing 64,588 non-convertible debentures at ₹25,000 face value each, following SEBI's approval to proceed with its IPO. The debt was raised from institutional investors including California-based Kairos Ventures, Real Capital Financial Services, and Mumbai-based Texport International, alongside angel investors. PSL's FY25 loss surged 295% to ₹189 Cr from ₹47.7 Cr in the prior fiscal year, driven by an exceptional item related to employee stock option grants.AijournKairos Ventures Clarifies Reasons for Reduction in Shareholding in Sivers SemiconductorsKairos Ventures reduced its shareholding in Sivers Semiconductors AB, and Sivers issued a clarification on March 26, 2026, stating the reduction was due to periodic fund-level rebalancing and payment of fund expenses at Kairos. Todd Thomson, COO of Kairos Ventures and board member of Sivers Semiconductors, emphasized that both Kairos and he personally maintain strong conviction in Sivers' long-term potential, with his personal shareholdings remaining intact. The disclosure appears to be a routine investor relations clarification rather than a significant corporate development.PR NewswireKairos Ventures Clarifies Reasons for Reduction in Shareholding in Sivers SemiconductorsKairos Ventures reduced its shareholding in Sivers Semiconductors AB, as disclosed through the insider register on March 25, 2026, with the reduction attributed to periodic fund level rebalancing and payment of fund expenses at Kairos. The company's Chief Operating Officer and Sivers board member stated that both Kairos and himself personally maintain strong conviction in Sivers Semiconductors' long-term potential and that his personal shareholdings remain intact.Investing.comActuate therapeutics director Kairos Venture Partners II, L.P. sells $1.6m in shares By Investing.comKairos Venture Partners II, L.P., a director and ten percent owner of Actuate Therapeutics, sold 280,000 shares of common stock on January 5, 2026, at $5.8 per share, totaling $1,624,000. Following the transaction, ACTU shares have climbed to $6.73, representing an 8.82% gain over the past week, with the stock trading near its fair value according to InvestingPro analysis. The Kairos Funds, managed by Kairos Venture Investments, LLC, collectively hold a significant stake in Actuate Therapeutics following this sale.KairosventuresA Kairos Ventures Portfolio CompanyGuRu, a portfolio company of Kairos Ventures, is developing the world's first true wireless power transmission technology that integrates power, data, and sensing capabilities into a single chip. The company utilizes its own advanced IP alongside intellectual property licensed from the California Institute of Technology (Caltech) to target mass production.Startup BusinessKairos Ventures partecipa al round da 4M € in Underscore DistrictKairos Ventures ESG One has participated in a funding round of over 4 million euros for Underscore District, an accelerator specializing in Italian luxury and fashion brands. The investment aims to support Underscore District's growth and expansion of its portfolio, which includes brands such as Piumestudio and Magliano. This marks the seventh investment for Kairos Ventures, broadening its focus into the fashion sector.BeBeezViceversa incassa round di Serie A da 10 mln euro. Lo guidano CDP Venture Capital, Azimut Digitech, Kairos Ventures e gli angeli di IAGViceversa, a fintech specializing in revenue-based financing for digital businesses, has closed its Series A funding round with a €10 million raise. The investment was led by CDP Venture Capital and included co-investors such as Azimut Digitech, Kairos Ventures, and Italian Angels for Growth, bringing the company's total fundraising to €33 million. This capital supports Viceversa's expansion across six European countries and the development of new embedded finance solutions.FinSMEsKairos Ventures Closes Third Fund at $58 MillionKairos Ventures closed its third fund at $58 million, making 27 investments in companies like Vivodyne, PteroDynamics, and Linnaeus. The remaining funds will primarily support existing investments. The firm, founded in 2015, has invested in over 55 companies since inception.PR NewswireKairos Ventures Closes Third Fund at $58 MillionKairos Ventures closed its third fund with $58 million in capital commitments. The fund has made 27 investments in companies like Vivodyne, PteroDynamics, and Linnaeus, and is nearly fully invested. Remaining funds will support existing investments.